We are live on ! Find out more
GFM

GF Fund Management Portfolio holdings

AUM $8.34B
1-Year Est. Return 165.53%
This Fund
S&P 500
This Quarter Est. Return
+77.9%
1 Year Est. Return
+165.53%
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$8.34B
AUM Growth
+$2.35B
Cap. Flow
-$42M
Cap. Flow %
-0.5%
Top 10 Hldgs %
46.57%
Holding
644
New
20
Increased
132
Reduced
424
Closed
57

Top Buys

Rank Stock Value
1
INIO
INNIO N.V.
INIO
+$177M
2
AMD icon
Advanced Micro Devices
AMD
+$119M
3
FORM icon
FormFactor
FORM
+$101M
4
CBRS
Cerebras Systems
CBRS
+$70.1M
5
ONTO icon
Onto Innovation
ONTO
+$64.5M

Top Sells

Rank Stock Value
1
TSEM icon
Tower Semiconductor
TSEM
+$220M
2
LITE icon
Lumentum
LITE
+$219M
3
TSLA icon
Tesla
TSLA
+$50.1M
4
CIEN icon
Ciena
CIEN
+$43.3M
5
MSFT icon
Microsoft
MSFT
+$42.6M

Sector Composition

Rank Sector Weight
1 Technology 66.11%
2 Communication Services 9.64%
3 Consumer Discretionary 8.42%
4 Industrials 4.35%
5 Healthcare 4.17%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
COO icon
226
Cooper Companies
COO
$13.6B
$395K ﹤0.01%
5,509
+58
+1% +$3.79K
VICI icon
227
VICI Properties
VICI
$28B
$389K ﹤0.01%
14,664
-1,453
-9% -$40.7K
WKC icon
228
World Kinect Corp
WKC
$1.81B
$385K ﹤0.01%
11,685
-6,683
-36% -$186K
MFC icon
229
Manulife Financial
MFC
$73.5B
$376K ﹤0.01%
9,279
– –
NEE icon
230
NextEra Energy
NEE
$174B
$366K ﹤0.01%
4,172
-888
-18% -$80.3K
TALO icon
231
Talos Energy
TALO
$2.81B
$363K ﹤0.01%
28,107
-13,996
-33% -$209K
AVB
232
DELISTED
AvalonBay Communities
AVB
$353K ﹤0.01%
1,869
-284
-13% -$51.3K
ASND icon
233
Ascendis Pharma A/S
ASND
$17.7B
$348K ﹤0.01%
1,305
-74
-5% -$17.3K
NBIX icon
234
Neurocrine Biosciences
NBIX
$15.8B
$335K ﹤0.01%
1,987
-253
-11% -$37.5K
MEDP icon
235
Medpace
MEDP
$16.5B
$320K ﹤0.01%
604
-28
-4% -$12.9K
JAZZ icon
236
Jazz Pharmaceuticals
JAZZ
$16B
$314K ﹤0.01%
1,305
-59
-4% -$12.9K
ALGN icon
237
Align Technology
ALGN
$11.3B
$313K ﹤0.01%
1,858
+19
+1% +$3.3K
IBM icon
238
IBM
IBM
$221B
$310K ﹤0.01%
1,103
– –
VMRK
239
Vivmark Residential
VMRK
$50.6B
$308K ﹤0.01%
4,538
-946
-17% -$61.3K
BBIO icon
240
BridgeBio Pharma
BBIO
$14.6B
$306K ﹤0.01%
4,103
-225
-5% -$15.8K
CRL icon
241
Charles River Laboratories
CRL
$13.8B
$304K ﹤0.01%
1,339
+14
+1% +$2.49K
PODD icon
242
Insulet
PODD
$10.2B
$303K ﹤0.01%
1,991
+21
+1% +$3.5K
TECH icon
243
Bio-Techne
TECH
$11.4B
$301K ﹤0.01%
4,258
+45
+1% +$2.43K
BAX icon
244
Baxter International
BAX
$13.4B
$299K ﹤0.01%
14,029
+148
+1% +$2.76K
SOLV icon
245
Solventum
SOLV
$15.6B
$294K ﹤0.01%
3,808
+40
+1% +$2.92K
REX icon
246
REX American Resources
REX
$1.38B
$291K ﹤0.01%
6,445
-2,825
-30% -$131K
HD icon
247
Home Depot
HD
$320B
$290K ﹤0.01%
821
– –
KOS icon
248
Kosmos Energy
KOS
$1.66B
$285K ﹤0.01%
134,975
-28,726
-18% -$80K
IONS icon
249
Ionis Pharmaceuticals
IONS
$9.65B
$277K ﹤0.01%
3,497
-140
-4% -$10.5K
EXEL icon
250
Exelixis
EXEL
$14.6B
$270K ﹤0.01%
4,966
-1,056
-18% -$51.4K
8 9
10
11 12

Similar funds

GLF
Groupe la Francaise Paris, France $8.31B AUM 37.53% 1-Year Est. Return
PS
Principal Securities Des Moines, Iowa $8.31B AUM 21.94% 1-Year Est. Return
CFG
Citizens Financial Group Providence, Rhode Island $8.3B AUM 27.66% 1-Year Est. Return
MAM
Madison Asset Management Madison, Wisconsin $8.39B AUM 16.36% 1-Year Est. Return
FLPIM
F.L. Putnam Investment Management Lynnfield, Massachusetts $8.39B AUM 37.75% 1-Year Est. Return
MWM
Modern Wealth Management Lenexa, Kansas $8.4B AUM 21.02% 1-Year Est. Return
HCM
Howard Capital Management Roswell, Georgia $8.4B AUM 51.89% 1-Year Est. Return
OCA
OpenArc Corporate Advisory Atlanta, Georgia $8.41B AUM

GF Fund Management's Q2 2026 Portfolio in Review

As of Q2 2026, GF Fund Management held 644 positions worth $8.34B, up 39% from $5.98B the previous quarter. Its ten largest holdings account for 47% of the portfolio.

GF Fund Management's Q2 2026 filing shows 20 new, 132 increased, 424 reduced and 57 closed positions. Its largest new stake was INNIO N.V.: 4,970,000 shares worth $197M. The largest sale was Tower Semiconductor, an estimated $220M.

By sector, the portfolio is most concentrated in Technology at 66% of assets, up from 54% a quarter earlier, followed by Communication Services and Consumer Discretionary.

  • GF Fund Management's largest Q2 2026 buy was INNIO N.V.: 4,970,000 shares worth $197M.
  • GF Fund Management added most to Advanced Micro Devices in Q2 2026, an estimated $119M increase.
  • GF Fund Management's biggest Q2 2026 reduction was Tower Semiconductor, cutting an estimated $220M.
  • GF Fund Management fully exited Coherent in Q2 2026, selling an estimated $23.3M.
  • GF Fund Management's ten largest holdings make up 47% of its $8.34B portfolio in Q2 2026.
  • GF Fund Management opened 20 new positions and closed 57 in Q2 2026.
  • GF Fund Management's portfolio value rose 39% quarter-over-quarter to $8.34B.

Based on GF Fund Management's 13F filing for Q2 2026, filed 7 Aug 2026.